Search

Toxicity tests in rodents are still considered a controversial topic concerning their ethical justifiability. The chick embryo chorioallantoic membrane (CAM) assay may offer a simple and inexpensive alternative. The CAM assay is easy to perform and has low bureaucratic hurdles. At the same time, the CAM assay allows the application of a broad variety of analytical methods in the field of nanotoxicological research. We evaluated the CAM assay as a methodology for the determination of nanotoxicity. Therefore we calculated the median lethal dose (LD50), performed in vivo microscopy and immunohistochemistry to identify organ-specific accumulation profiles, potential organ damage, and the kinetics of the in vivo circulation of the nanoparticles. Zinc oxide nanoparticles were intravascularly injected on day 10 of the egg development and showed an LD50 of 17.5 µM (1.4 µg/mLeggcontent). In comparison, the LD50 of equivalent amounts of Zn2+ was 4.6 µM (0.6 µg/mLeggcontent). Silica encapsulated ZnO@SiO2 nanoparticles conjugated with fluorescein circulated in the bloodstream for at least 24 h. Particles accumulated mostly in the liver and kidney. In immunohistochemical staining, organ damage was detected only in liver tissue after intravascular injection of zinc oxide nanoparticles in very high concentrations. Zinc oxide nanoparticles showed a different pharmacokinetic profile compared to Zn2+ ions. In conclusion, the CAM assay has proven to be a promising methodology for evaluating nanotoxicity and for the assessment of the in vivo accumulation profiles of nanoparticles. These findings may qualify the methodology for risk assessment of innovative nanotherapeutics in the future. [ABSTRACT FROM AUTHOR]

Non-hydrolytic sol-gel synthesis provides a low temperature solution based approach to solid-state materials. In this work, reactions of TaX (X = F, Cl, Br, I) with the thio-ethers di- tert-butylsulfide and hexamethyldisilathiane were carried out in chloroform or acetonitrile. The influence of synthetic parameters such as temperature, reaction time, starting sulfur to tantalum ratio, and solvent volume were explored, and optimized conditions for the preparation of phase pure crystalline TaS were established. Amorphous powders were recovered for most of the samples, but crystalline 1T- and 3R-TaS modifications could be selectively prepared by heat treatments of the as-recovered precursors at 700 and 800 °C, respectively. The crystallite sizes could be adjusted by tuning the starting sulfur to tantalum ratios, and by choice of solvent. For specific conditions, nanocrystalline 1T-TaS was directly recovered from solution. To our knowledge, this is the first time that crystalline TaS was directly obtained from low temperature solution based routes. [ABSTRACT FROM AUTHOR]